Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic saline plus furosemide in decompensated heart failure with inadequate diuretic response
IRCT20190325043107N76Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of hypertonic saline and furosemide in heart failure (HF), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Change in volume status. Started Jul 2026; status: completed.
02
Drugs
hypertonic salinefurosemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on IRCT20190325043107N76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N76.